Risk of cervical cancer associated with extending the interval between cervical-cancer screenings

George F. Sawaya, Kenneth (John) McConnell, Shalini L. Kulasingam, Herschel W. Lawson, Karla Kerlikowske, Joy Melnikow, Nancy C. Lee, Ginny Gildengorin, Evan R. Myers, A. Eugene Washington

Research output: Contribution to journalArticle

110 Citations (Scopus)

Abstract

BACKGROUND: Although contemporary guidelines suggest that the intervals between Papanicolaou tests can be extended to three years among low-risk women with previous negative tests, the excess risk of cervical cancer associated with less frequent than annual screening is uncertain. METHODS: We determined the prevalence of biopsy-proven cervical neoplasia among 938,576 women younger than 65 years of age, stratified according to the number of previous consecutive negative Papanicolaou tests. Using a Markov model that estimates the rate at which dysplasia will progress to cancer, we estimated the risk of cancer within three years after one or more negative Papanicolaou tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that would be required to avert one case of cancer given a particular interval between screenings. RESULTS: Among 31,728 women 30 to 64 years of age who had had three or more consecutive negative tests, the prevalence of biopsy-proven cervical intraepithelial neoplasia of grade 2 was 0.028 percent and the prevalence of grade 3 neoplasia was 0.019 percent; none of the women had invasive cervical cancer. According to our model, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 among women 30 to 44 years of age, 1 in 100,000 among women 45 to 59 years of age, and 1 in 100,000 among women 60 to 64 years of age; these risks would be 5 in 100,000, 2 in 100,000, and 1 in 100,000, respectively, if screening were performed once three years after the last negative test. To avert one additional case of cancer by screening 100,000 women annually for three years rather than once three years after the last negative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to 44 years of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age. CONCLUSIONS: As compared with annual screening for three years, screening performed once three years after the last negative test in women 30 to 64 years of age who have had three or more consecutive negative Papanicolaou tests is associated with an average excess risk of cervical cancer of approximately 3 in 100,000.

Original languageEnglish (US)
Pages (from-to)1501-1509
Number of pages9
JournalNew England Journal of Medicine
Volume349
Issue number16
DOIs
StatePublished - Oct 16 2003

Fingerprint

Early Detection of Cancer
Uterine Cervical Neoplasms
Papanicolaou Test
Neoplasms
Biopsy
Cervical Intraepithelial Neoplasia
Guidelines

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sawaya, G. F., McConnell, K. J., Kulasingam, S. L., Lawson, H. W., Kerlikowske, K., Melnikow, J., ... Washington, A. E. (2003). Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. New England Journal of Medicine, 349(16), 1501-1509. https://doi.org/10.1056/NEJMoa035419

Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. / Sawaya, George F.; McConnell, Kenneth (John); Kulasingam, Shalini L.; Lawson, Herschel W.; Kerlikowske, Karla; Melnikow, Joy; Lee, Nancy C.; Gildengorin, Ginny; Myers, Evan R.; Washington, A. Eugene.

In: New England Journal of Medicine, Vol. 349, No. 16, 16.10.2003, p. 1501-1509.

Research output: Contribution to journalArticle

Sawaya, GF, McConnell, KJ, Kulasingam, SL, Lawson, HW, Kerlikowske, K, Melnikow, J, Lee, NC, Gildengorin, G, Myers, ER & Washington, AE 2003, 'Risk of cervical cancer associated with extending the interval between cervical-cancer screenings', New England Journal of Medicine, vol. 349, no. 16, pp. 1501-1509. https://doi.org/10.1056/NEJMoa035419
Sawaya, George F. ; McConnell, Kenneth (John) ; Kulasingam, Shalini L. ; Lawson, Herschel W. ; Kerlikowske, Karla ; Melnikow, Joy ; Lee, Nancy C. ; Gildengorin, Ginny ; Myers, Evan R. ; Washington, A. Eugene. / Risk of cervical cancer associated with extending the interval between cervical-cancer screenings. In: New England Journal of Medicine. 2003 ; Vol. 349, No. 16. pp. 1501-1509.
@article{55c60d38c3c74f16b8a2350d44ea6771,
title = "Risk of cervical cancer associated with extending the interval between cervical-cancer screenings",
abstract = "BACKGROUND: Although contemporary guidelines suggest that the intervals between Papanicolaou tests can be extended to three years among low-risk women with previous negative tests, the excess risk of cervical cancer associated with less frequent than annual screening is uncertain. METHODS: We determined the prevalence of biopsy-proven cervical neoplasia among 938,576 women younger than 65 years of age, stratified according to the number of previous consecutive negative Papanicolaou tests. Using a Markov model that estimates the rate at which dysplasia will progress to cancer, we estimated the risk of cancer within three years after one or more negative Papanicolaou tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that would be required to avert one case of cancer given a particular interval between screenings. RESULTS: Among 31,728 women 30 to 64 years of age who had had three or more consecutive negative tests, the prevalence of biopsy-proven cervical intraepithelial neoplasia of grade 2 was 0.028 percent and the prevalence of grade 3 neoplasia was 0.019 percent; none of the women had invasive cervical cancer. According to our model, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 among women 30 to 44 years of age, 1 in 100,000 among women 45 to 59 years of age, and 1 in 100,000 among women 60 to 64 years of age; these risks would be 5 in 100,000, 2 in 100,000, and 1 in 100,000, respectively, if screening were performed once three years after the last negative test. To avert one additional case of cancer by screening 100,000 women annually for three years rather than once three years after the last negative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to 44 years of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age. CONCLUSIONS: As compared with annual screening for three years, screening performed once three years after the last negative test in women 30 to 64 years of age who have had three or more consecutive negative Papanicolaou tests is associated with an average excess risk of cervical cancer of approximately 3 in 100,000.",
author = "Sawaya, {George F.} and McConnell, {Kenneth (John)} and Kulasingam, {Shalini L.} and Lawson, {Herschel W.} and Karla Kerlikowske and Joy Melnikow and Lee, {Nancy C.} and Ginny Gildengorin and Myers, {Evan R.} and Washington, {A. Eugene}",
year = "2003",
month = "10",
day = "16",
doi = "10.1056/NEJMoa035419",
language = "English (US)",
volume = "349",
pages = "1501--1509",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "16",

}

TY - JOUR

T1 - Risk of cervical cancer associated with extending the interval between cervical-cancer screenings

AU - Sawaya, George F.

AU - McConnell, Kenneth (John)

AU - Kulasingam, Shalini L.

AU - Lawson, Herschel W.

AU - Kerlikowske, Karla

AU - Melnikow, Joy

AU - Lee, Nancy C.

AU - Gildengorin, Ginny

AU - Myers, Evan R.

AU - Washington, A. Eugene

PY - 2003/10/16

Y1 - 2003/10/16

N2 - BACKGROUND: Although contemporary guidelines suggest that the intervals between Papanicolaou tests can be extended to three years among low-risk women with previous negative tests, the excess risk of cervical cancer associated with less frequent than annual screening is uncertain. METHODS: We determined the prevalence of biopsy-proven cervical neoplasia among 938,576 women younger than 65 years of age, stratified according to the number of previous consecutive negative Papanicolaou tests. Using a Markov model that estimates the rate at which dysplasia will progress to cancer, we estimated the risk of cancer within three years after one or more negative Papanicolaou tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that would be required to avert one case of cancer given a particular interval between screenings. RESULTS: Among 31,728 women 30 to 64 years of age who had had three or more consecutive negative tests, the prevalence of biopsy-proven cervical intraepithelial neoplasia of grade 2 was 0.028 percent and the prevalence of grade 3 neoplasia was 0.019 percent; none of the women had invasive cervical cancer. According to our model, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 among women 30 to 44 years of age, 1 in 100,000 among women 45 to 59 years of age, and 1 in 100,000 among women 60 to 64 years of age; these risks would be 5 in 100,000, 2 in 100,000, and 1 in 100,000, respectively, if screening were performed once three years after the last negative test. To avert one additional case of cancer by screening 100,000 women annually for three years rather than once three years after the last negative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to 44 years of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age. CONCLUSIONS: As compared with annual screening for three years, screening performed once three years after the last negative test in women 30 to 64 years of age who have had three or more consecutive negative Papanicolaou tests is associated with an average excess risk of cervical cancer of approximately 3 in 100,000.

AB - BACKGROUND: Although contemporary guidelines suggest that the intervals between Papanicolaou tests can be extended to three years among low-risk women with previous negative tests, the excess risk of cervical cancer associated with less frequent than annual screening is uncertain. METHODS: We determined the prevalence of biopsy-proven cervical neoplasia among 938,576 women younger than 65 years of age, stratified according to the number of previous consecutive negative Papanicolaou tests. Using a Markov model that estimates the rate at which dysplasia will progress to cancer, we estimated the risk of cancer within three years after one or more negative Papanicolaou tests, as well as the number of additional Papanicolaou tests and colposcopic examinations that would be required to avert one case of cancer given a particular interval between screenings. RESULTS: Among 31,728 women 30 to 64 years of age who had had three or more consecutive negative tests, the prevalence of biopsy-proven cervical intraepithelial neoplasia of grade 2 was 0.028 percent and the prevalence of grade 3 neoplasia was 0.019 percent; none of the women had invasive cervical cancer. According to our model, the estimated risk of cancer with annual Papanicolaou tests for three years was 2 in 100,000 among women 30 to 44 years of age, 1 in 100,000 among women 45 to 59 years of age, and 1 in 100,000 among women 60 to 64 years of age; these risks would be 5 in 100,000, 2 in 100,000, and 1 in 100,000, respectively, if screening were performed once three years after the last negative test. To avert one additional case of cancer by screening 100,000 women annually for three years rather than once three years after the last negative test, an average of 69,665 additional Papanicolaou tests and 3861 colposcopic examinations would be needed in women 30 to 44 years of age and an average of 209,324 additional Papanicolaou tests and 11,502 colposcopic examinations in women 45 to 59 years of age. CONCLUSIONS: As compared with annual screening for three years, screening performed once three years after the last negative test in women 30 to 64 years of age who have had three or more consecutive negative Papanicolaou tests is associated with an average excess risk of cervical cancer of approximately 3 in 100,000.

UR - http://www.scopus.com/inward/record.url?scp=0141940149&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141940149&partnerID=8YFLogxK

U2 - 10.1056/NEJMoa035419

DO - 10.1056/NEJMoa035419

M3 - Article

C2 - 14561792

AN - SCOPUS:0141940149

VL - 349

SP - 1501

EP - 1509

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 16

ER -